Lindbrook Capital, LLC Argenx Se Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Argenx Se stock. As of the latest transaction made, Lindbrook Capital, LLC holds 201 shares of ARGX stock, worth $126,292. This represents 0.01% of its overall portfolio holdings.

Number of Shares

201

Previous 190 5.79%

Holding current value

$126,292

Previous $81,000 34.57%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$434.22 - $551.9 $4,776 - $6,070	11 Added 5.79%	201 $109,000
Q2 2024 Jul 31, 2024	SELL	$356.01 - $451.55 $2,492 - $3,160	-7 Reduced 3.55%	190 $81,000
Q1 2024 Apr 25, 2024	BUY	$356.95 - $413.29 $13,207 - $15,291	37 Added 23.13%	197 $77,000
Q4 2023 Jan 31, 2024	BUY	$338.91 - $506.01 $1,355 - $2,024	4 Added 2.56%	160 $60,000
Q3 2023 Oct 25, 2023	BUY	$369.35 - $548.43 $4,432 - $6,581	12 Added 8.33%	156 $76,000
Q2 2023 Jul 28, 2023	BUY	$360.14 - $422.58 $1,800 - $2,112	5 Added 3.6%	144 $56,000
Q1 2023 Apr 26, 2023	SELL	$334.23 - $403.65 $2,673 - $3,229	-8 Reduced 5.44%	139 $51,000
Q4 2022 Jan 24, 2023	SELL	$342.17 - $402.31 $4,106 - $4,827	-12 Reduced 7.55%	147 $0
Q3 2022 Nov 10, 2022	BUY	$343.2 - $395.75 $5,148 - $5,936	15 Added 10.42%	159 $56,000
Q2 2022 Aug 01, 2022	BUY	$269.58 - $378.88 $9,435 - $13,260	35 Added 32.11%	144 $55,000
Q1 2022 Apr 21, 2022	SELL	$254.45 - $351.06 $11,704 - $16,148	-46 Reduced 29.68%	109 $34,000
Q4 2021 Jan 18, 2022	BUY	$272.01 - $353.03 $6,528 - $8,472	24 Added 18.32%	155 $54,000
Q3 2021 Nov 05, 2021	BUY	$295.0 - $350.58 $9,145 - $10,867	31 Added 31.0%	131 $40,000
Q2 2021 Jul 27, 2021	BUY	$257.11 - $319.92 $2,056 - $2,559	8 Added 8.7%	100 $30,000
Q1 2021 Apr 28, 2021	BUY	$268.3 - $380.31 $3,487 - $4,944	13 Added 16.46%	92 $25,000
Q4 2020 Jan 27, 2021	BUY	$248.13 - $308.36 $3,473 - $4,317	14 Added 21.54%	79 $23,000
Q3 2020 Nov 03, 2020	BUY	$215.51 - $272.51 $3,879 - $4,905	18 Added 38.3%	65 $17,000
Q1 2020 Apr 22, 2020	BUY	$108.83 - $165.23 $870 - $1,321	8 Added 20.51%	47 $6,000
Q1 2019 Apr 23, 2019	BUY	$98.85 - $134.59 $3,855 - $5,249	39 New	39 $4,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Argenx Se Transaction History